Work Area: Patents

Latest content

USPTO reports strong finances despite a fall in patent filings

Increased fees helped the office's budget escape unscathed from a drop in applications, and the agency expects 1.5% growth in patenting this year

19 January 2022

Building blocks for the metaverse – practical IP considerations for NFT investors and creators

Nader Mousavi, Mehdi Ansari, Jay Thornton and Jonathan Hofman of Sullivan & Cromwell explore the legal issues facing creators and buyers of NFTs, alongside the regulatory frameworks in which they are being used

19 January 2022

WHO’s vaccine successes show significance of Moderna covid IP pledge

African tech transfer hub is making fast progress in replicating the approved mRNA jab

18 January 2022

Ericsson sues Apple for patent infringement as cross-licence deal expires

Swedish telco asserts patents against the iPhone maker in the Western District of Texas and at least one jurisdiction outside the US

18 January 2022

Draft Biden SEP policy favours implementers, but even they may still flock to other jurisdictions

Finnegan attorneys Erik Puknys and Michelle Rice explain that while the proposed DOJ/NIST/USPTO FRAND framework is good for implementers, it may not be enough to make the US stand out in global forum competition

17 January 2022

Without injunctions, the US patent system is rigged in favour of deep pocket defendants

Sonos’s recent win over Google at the ITC demonstrates the importance of innovators having the ability to exclude infringers from practising on their inventions

14 January 2022

Skinny label concerns persist for generics, despite good news from Delaware

A district court judge has thrown out an induced infringement allegation against Hikma Pharmaceutical, but big questions remain over drug label carve-outs

14 January 2022

Landmark Dusseldorf non-FRAND finding is big news for joint licensing programmes

SEP licensors will have to look again at duplicate royalty reimbursement policies following first-of-a-kind ruling

13 January 2022

VLSI claims “gamesmanship” in IPR attack on patent from $2 billion Intel verdict

Shell company’s validity challenge threatens the eye-watering damages award and Fortress-backed entity says it could open the door to abuse of the PTAB system

12 January 2022

mRNA vaccines: how to navigate the freedom-to-operate maze

The Long Read: Jeffrey Morton and Thomas Ehrich unpack the complex patent considerations surrounding one of the most important leaps forward in biotechnology

12 January 2022

Get unlimited access to all IAM content